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COMMENT
Leveraging genomic diversity to
promote human and animal health
Michèle Ramsay 1*, Han G. Brunner2,3 & Appolinaire Djikeng4
Genomic diversity is a driving force inﬂuencing human and animal health, and
susceptibility to disease. During the Keystone Symposium on Leveraging Genomic
Diversity to Promote Human and Animal Health held in Kampala on Lake Victoria in
Uganda, we brought together diverse communities of geneticists with primary
objectives to explore areas of common interest, joint technological and metho-
dological developments and applications, and to leverage opportunities for
cross-learning. We explored translational genomics research in farmed animals
and humans, debated the differences in research objectives in high- and low-
resourced environments, delved into infectious diseases and zoonoses affecting
humans and animals and considered diversity and cultural context at many
levels. The 109 participants were from 22 countries (13 in Africa) and included
44 global travel awardees from 9 countries, equal numbers of men and women,
of whom 31 were students and 13 senior investigators.
Meeting background
There are fundamental differences in the objectives of human genetics and animal genetics and
breeding. Human genetics is focused on the individual and the need to make an accurate
diagnosis that will inform the best treatment to ensure the best achievable health outcomes for
the individual and their immediate family. It is about providing biological insights, developing
more effective treatments and giving parental couples reproductive choices. On the other hand,
animal genetics and breeding are focused on the performance of single or groups of animals
against predetermined and accurately measurable parameters including but not limited to
productivity, adaptation/resilience, growth, tolerance/susceptibility to diseases, feed conversion
and energy utilization. This is achieved through the selection of desirable traits, a process that
has developed over several millennia, since the domestication of animals, and the ﬁeld has
experienced dramatic acceleration over the past two decades with the advent of the genomics era,
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as explained by Michel Georges. There have been remarkable
successes in animal breeding, leading to considerable genetic
improvement and gains supporting productivity (e.g. milk, meat
and egg production), adaptation, growth and other key traits.
These signiﬁcant genetic gains have also brought about an added
environmental bonus in the form of a reduced carbon footprint.
This report provides some of the highlights and insights from the
deliberations during the four-day meeting.
Common tools and approaches between human genetics and
animal genetics and breeding
Since our understanding of genome–phenome correlation is
premised on good data, there were debates about the most suitable
technologies to provide us with accurate reference genomes to sti-
mulate the discovery of novel insights and a more accurate
understanding of the biological mechanisms. Long-range sequen-
cing and single-molecule sequencing technologies are coming of age
and promise to provide more accurate and complete reference
genomes. This will ensure that the genomes of all species are more
fully characterized, especially with regard to copy-number variants
(CNVs) and other structural variations that are predicted to have a
profound impact on biological processes.
Evolution and genome adaptation were a constant refrain
throughout the sessions. Evan Eichler presented the Keynote
Address on the relevance of primate evolution to human and ani-
mal health. He explained that segmental duplications, ranging
upwards from 50 bp (with CNVs now having been redeﬁned to a
lower threshold from the previous 1000-bp limit) have been
understudied in most species as they are often intractable when
analyzing short-read sequences. The duplication events can occur
within chromosomes (intra-segmental duplications) or between
chromosomes (inter-segmental duplications) and create regions of
potential instability and hotspots for non-homologous crossover
events. All primates, including humans, have extensive intra- and
inter-segmental duplication events, whereas all other animals that
have been studied have abundant intra- but relatively fewer inter-
segmental duplication events. Hitching a ride with these events are
gene families that have expanded uniquely in humans and include
genes involved in immune response and toxin exposure.
In humans, signals of selection reﬂect local and regional adap-
tations to diet (AMY1—amylase gene), to increased levels of arsenic
in ground water supplies (AS3MT) and to pathogen infections
(Lassa fever, Yellow fever, malaria, trypanosomiasis and dengue).
Charles Rotimi explained that the protective alleles often reach high
frequencies in regions of the highest and longest exposure and when
people migrate out to other geographic locations, they take the
variants with them. In admixed populations, speciﬁc variants can be
correlated with the percentage of ancestry from a speciﬁc location.
One example is where lower levels of LDL cholesterol and higher
levels of triglycerides are correlated with an increased proportion of
African ancestry. Louisa Pereira brought fascinating insights
showing that an increased level of population-based genetic resis-
tance to dengue was correlated with African ancestry.
Integrating big data, machine learning and artiﬁcial
intelligence to investigate and establish linkages between
genotypes and phenotypes
Large public genomic and other omic resources so familiar in the
human research landscape (e.g. 1000 Genomes Project,
ENCODE, GTEx, the UK Biobank and many others), with portals
for sharing the outcomes of massive analyses (e.g. providing
information through genome browsers like https://www.ensembl.
org/index.html and https://genome.ucsc.edu/, and http://
geneatlas.roslin.ed.ac.uk/) are paralleled in the animal research
community by, for example, the 1000 Bull Genomes Project
(http://www.1000bullgenomes.com/), the International Goat
Genome Consortium (http://www.goatgenome.org) and poultry
genome consortia, as elaborated on by Niklas Blomberg. These
initiatives pool data and resources to develop databases and tools
for research, including SNP genotyping arrays for genome-wide
association studies, and set standards for global data sharing (e.g.
The Global Alliance for Genomics and Health (GA4GH)—
https://www.ga4gh.org/). Both the animal and human genetics
communities are well aware of the need for systems biology
research approaches and are developing resources that explore
epigenomes, transcriptomes, eQTLs and microbiomes in the
context of health and disease, as well as agricultural productivity
in the case of animals. International data resources are receiving
much attention, and different models and processes used to assess
data are being adopted. These vast data resources provide
opportunities for machine-learning approaches, by integrating
human, animal and pathogen data, and promote a better
understanding of the linkages between genotypes and pheno-
types. Some discussion points from the meeting on different
approaches to single-gene disorders and complex multifactorial
diseases are given below.
Understanding the genetic basis of monogenic traits is
important for several reasons: providing an accurate diagnosis,
guiding treatment, providing alternate therapeutic approaches
and informing reproductive choices, as discussed by Han Brun-
ner. The wide application of next-generation sequencing tech-
nologies has revealed that every baby is born with 70–100 novel
mutations, not present in either parent. Although often benign,
these mutations could lead to serious disorders. While recessive
diseases dominate in populations with high consanguinity, new
mutations are the main cause of neurodevelopmental disorders
such as intellectual disability and autism in outbred populations.
The links between genetic mutation and phenotype are increas-
ingly being uncovered in the ﬁeld of medical genetics and play an
important role in patient management and care. Brunhilde Wirth
used the example of spinal muscular atrophy to explain how
recent advances and knowledge of the genetics of disease has
helped to develop more targeted therapies, by presenting both
signiﬁcant challenges and much promise.
In the world of animal genetics and breeding, there are good
examples of monogenic traits or large-effect variants that have been
sought by breeders (e.g. polled cattle, hair coverage and length and
PRRS resistance in pigs, as explained by Simon Lillico). Attempts to
establish the desired alleles to ﬁxation in herds have sometimes been
hampered by the hitch-hiking of undesirable traits. Genome-editing
technologies are now being considered as they target only the gene
of interest, but this approach has led to safety and ethical concerns
among sectors of the public as illustrated in the presentation by
Alison van Eenennaam. It is, however, a potentially revolutionary
technology for boosting agricultural production and lowering costs
and adverse environmental impacts.
In the animal world, it is common to refer to breeding value
and preservation of germplasm of individuals and their potential
impact on the development of the herd. John Hickey led us
through the process of how a deep understanding of the rela-
tionship between the genetic variants and the phenotype can be
applied to the notion that an embryo’s potential value can be
determined even before the phenotype is fully formed. Although
there are important monogenic traits relevant to animal breeding,
most desirable traits are polygenic and multifactorial, like milk
production and fat content in cattle. The shorter generation time
and control over the environment, for example in terms of diet,
temperature and exposures, make it more tractable to assess and
predict the phenotypic outcome among animals. David Evans
provided excellent explanations on how to assess genetic causality
in the context of complex traits. Susan Lamont spoke about
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genetic associations for traits in poultry breeding and Mark Fife
on the diversity of immune loci in Europe and Africa.
On the other hand, in terms of public health applications for
genomics, Michele Ramsay explained that there is much interest
in polygenic risk scores (PRSs), with the purpose of stratifying
human populations to identify those at the highest risk for spe-
ciﬁc diseases. This would provide opportunities for interventions
to prevent or ameliorate disease through targeted treatment. The
consensus at the meeting was that this is not yet a practical
approach, especially for understudied populations like those in
Africa. We were also reminded that PRSs can only be as good as
the proportional heritability of the trait under investigation, a
point often ignored or minimized by proponents of genomic
medicine in the context of complex traits.
Landscape genomics: is there a human equivalent?
The term ‘landscape genomics' is commonly used in the animal
ﬁeld as explained by Farai Muchadeyi. It refers to the animals and
their genomes, in the context of geography, rainfall, temperature,
humidity, vegetation and pathogens. One example is the adap-
tation of cattle to their local environment where Bos taurus (e.g.
the Hereford) thrives in humid temperate European climates but
is poorly adapted to tropical and subtropical regions of Africa and
elsewhere. Here the Bos indicus (e.g. the Brahman) with its longer
legs, smooth skin, abundant skin folds and hump, ﬂourishes.
Breeds are chosen or adapted to ensure optimal productivity,
resistance to pests and diseases and an overall resilience. Is there a
place for landscape genomics in human research? It is well known
that populations adapt to their environments over several mil-
lennia, and that recent migrations, relocations and changes in
lifestyle have important implications for health. Examples include
the development of vitamin D-deﬁcient rickets in darkly pig-
mented individuals who move to low UV exposure regions where
they do not have access to appropriate nutrition and the dramatic
increase in obesity at a population level in urbanizing commu-
nities where people have transitioned to a calorie-rich diet and
sedentary lifestyle. Research that explores the optimal environ-
ment (e.g. diet and behavioural patterns) for people, given their
genetic susceptibilities, may lead to stigmatization, despite its
intended objectives and would require sensitive public engage-
ment. Poor attempts at translational medicine include misleading
advertising in the ﬁeld of nutrigenomics that has promoted
questionable tests and dietary recommendations.
One health
Bassirou Bonfoh reminded delegates of the concept of One
Health that applies to humans, animals and the environment and
this found resonance among the group. Local, national and
international efforts are essential to integrate the work of multiple
disciplines towards optimising universal health.
An obvious focus for the meeting, at the intersection of animal
and human health, was zoonotic diseases. There were several
presentations on avian and swine ﬂu and pathogenic strains with
the ability to cross the species boundaries. However, it became
clear that knowledge of prevalence and distribution was scanty,
especially in Africa, and the urgency to fund the research leading
to the implementation of preventive measures is yet to receive
priority in an African context. An inspiring exception is the work
of Christian Happi and colleagues in Nigeria on rapid genomics-
based detection of outbreaks of infectious diseases such as Ebola
and Lassa virus fever.
Ethics aspects of animal and human genetics
Decision-making and autonomy are different between our animal
and human genetics communities in signiﬁcant ways. Ethics
committees ensure that any research on human participants
adheres to the four fundamental ethical principles: autonomy,
beneﬁcence, non-maleﬁcence and justice. Individuals or their
guardians are required to provide informed consent and need to
agree that their samples and data may be shared, if this is the
intention. In animal research, the emphasis is on respect and
balancing general welfare against beneﬁt, while minimizing
wastage by choosing appropriate sample sizes. Advanced
experiments in or involving animals are also reviewed by insti-
tutional animal use and care committees. The objectives can be
speciﬁcally for commercial gain and in some countries, the
decision to share beyond political borders becomes a government
decision, where the concept of genomic sovereignty is applied to
national fauna and ﬂora. Sharing data from the rich animal
genetic diversity can be harnessed to promote genetic improve-
ment. This is in line with the Nagoya Protocol on Access and
Beneﬁt Sharing that promotes fair and equitable sharing of the
beneﬁts that arise from the use of genetic resources (https://www.
cbd.int/).
Key messages from the meeting
There were four main areas where human and animal health
genomics intersected to generate interdisciplinary insights, lead-
ing to animated conversations around these subject areas:
Estimated breeding value in animals, genomic prediction and
cross-disorder genetic correlations in humans use very similar
analytical approaches and can learn from each other. In animal
breeding, the concept of Estimated Breeding Value is assigned to
animals and herds for single traits such as milk yield in cattle, to
complex health-related and economically valued traits. This
requires sophisticated complex genetics analyses across multiple
phenotypes. The animal (and plant) genetics and breeding
communities have created an entire suite of sophisticated analy-
tical tools to address these issues. In the area of human health,
this is echoed by efforts to detect cross-disorder genetic correla-
tions, and pleiotropy. Many of the analytical tools developed in
the animal genetics community are now being applied to analyze
large human health trait datasets.
The role of migration in determining patterns of disease sus-
ceptibility allele frequencies in humans closely mirrors the
concept of Landscape Genetics/Genomics in animal breeding.
Migration from one continent or area to another creates different
gene–environment interactions relevant to human health. This is
still underrecognized by medical professionals, and can lead to
suboptimal healthcare. In animal breeding, moving a breed to a
new environment similarly creates new challenges, which should
ﬁrst be recognized and then explored, and in some cases har-
nessed to introduce new measurable traits. Many pertinent
examples were discussed in the meeting.
All of human health and all of animal health are connected,
and have been for many thousands of years. The One Health
concept as deﬁned by the World Health Organization (https://www.
who.int/features/qa/one-health/en/) speciﬁcally recognizes that the
health of people is connected to the health of animals and the
environment. Zoonotic diseases are a pertinent example, and many
examples were discussed in the meeting. These re-enforced the
notion of a very clear interaction (including various dynamics)
between humans and animals, especially in the context of infectious
diseases. Sophisticated genomics tools exist to monitor the related
dynamics and even anticipate potential movement and adaptation
of disease agents (pathogens) between the human, animal and
environment interfaces. It became clear during the meeting that we
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need to think much more deeply about human–animal interactions,
and their dynamics, because the disease outbreaks are a symptom of
our complex cohabitation and interaction.
Ethics issues in human and animal health centre around the
same normative concept of what constitutes normal, versus
artiﬁcial or abnormal. Meeting participants grappled with key
ethical, moral, social and legal aspects of harnessing genetic
diversity for animal and human health. The ﬂexibility of what is
permissible in animals does not extend to humans, for example,
directed breeding for a desired outcome. Somatic and germline
genome editing has already been implemented for economically
driven objectives in agriculture and debate is shifting to indivi-
dual personal choice and the value of every life in medical
practice. Human genetics leverages the documentation of genetic
diversity, and its link to the phenotype, across the continents and
uses this to derive novel biological insights that can be translated
into therapies to treat and prevent the symptoms of diseases.
Responsible governance of data and biospecimens is a key ele-
ment to support research and discovery with an emphasis on
resource protection to avoid exploitation and potential stigmati-
zation of marginalized communities and leverage of rare breeds,
especially in low- to middle-income countries.
Leveraging infrastructure in LMICs
In regions and countries with resource constraints, infrastructure
platforms and data repositories can be shared for research in the
health and agricultural sectors. Similarly, analytic and interpretive
skills (e.g. biostatistics and bioinformatics) can be developed in
synergy to address the most urgent national and regional prio-
rities. Meetings such as the Keystone Symposium can bring key
stakeholders together.
The future—opportunities to explore, characterize and utilize
the remarkable animal and human genetic diversity that
exists in Africa and other parts of the world
Throughout the meeting, several unifying themes emerged.
We measure genetic variation and generate data in the same way
in animal and human genetics and have developed similar tech-
nological approaches. Our statistical analyses reﬂect universal
principles and applications to population genetics, and we strive
to better understand the relationship between genome variation
and phenotypes.
In addition to the personal networking and crossover of
technological approaches, such as the introduction of multiplexed
functional assays for all possible mutations in single human genes
(Lea Starita), assessing the genomic context of genetic variants
(Nicholas Katsanis) and predicting phenotype from polygenic
risk scores, we need to assess the future value of joint human and
animal genetics meetings. As we develop an appreciation for the
power of genome editing in the animal-breeding world and hotly
debate the ethics of this technology in a human context, we need
to ensure that the public is well informed and that we as scientists
keep the record straight (Alison van Eenennaam).
This meeting aimed to emphasize the practical implementation
of genomics approaches, and future joint animal/human genetics
meetings could target and explore speciﬁc approaches to animal
breeding that could be adapted to therapeutic avenues in a clinical
setting. In a continent like Africa where scientiﬁc resources
remain limited, science communication and access to knowledge
is essential (Elizabeth Marincola). A follow-on meeting in colla-
boration with local organizations (i.e. the African Academy of
Sciences, AAS; aasciences.ac.ke) could identify key themes to
foster a collaboration between the human and animal genetics
communities to strengthen funding applications, efﬁcient utili-
zation of resources and even engage with potential private sector
collaborators for product development, commercialization and
provision of services to drive animal genetic improvement and
human health.
Virtual content for the Keystone Symposium: Leveraging
Genomic Diversity to Promote Animal and Human Health
(available to the broad scientiﬁc community without cost).
Video insight—thought leader summary. https://youtu.be/
3fFdv43TXq0
Virtual access—poster abstracts, scientiﬁc talks video recording
and ePosters. http://bit.ly/VirtualAccess18S5
Virtual event—video discussion+Q&A. http://bit.ly/VKSgeno-
micdiversity
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